Oorsprong van het eerstegraads netwerk van Adam Shilling
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 14 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Adam Shilling via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Administrative Officer Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Baker Bros. Advisors LP
 Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Investment Managers | Founder Portfolio Manager-Equities | |
| University of Notre Dame | College/University | Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
Otsuka Pharmaceutical Development & Commercialization, Inc.
 Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ZS PHARMA INC | Pharmaceuticals: Major | Director/Board Member | |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Drexel University | College/University | Masters Business Admin | |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| McGill University | College/University | Doctorate Degree | |
| University of California, Los Angeles | College/University | Doctorate Degree | |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Undergraduate Degree | |
| University of Wisconsin | College/University | Undergraduate Degree | |
| Ursinus College | College/University | Undergraduate Degree | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| MERUS N.V. | Biotechnology | Director/Board Member | |
| FOUNDATION MEDICINE INC | Medical/Nursing Services | Corporate Officer/Principal | |
| Robert H. Smith School of Business | College/University | Masters Business Admin | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Director/Board Member | |
| LOXO ONCOLOGY INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin | |
| Harvard College | College/University | Undergraduate Degree | |
| The Indiana University School of Medicine | College/University | Corporate Officer/Principal | |
| Pritzker School of Medicine | College/University | Doctorate Degree | |
| New York University School of Social Work | College/University | Graduate Degree | |
| APTEVO THERAPEUTICS INC. | Biotechnology | Investor Relations Contact | |
| MADRIGAL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
Shire Pharmaceuticals LLC
 Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Biotechnology | Director/Board Member | |
| NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Human Resources Officer | |
| ALTIMMUNE, INC. | Biotechnology | Investor Relations Contact | |
| VOR BIOPHARMA INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a precision medicines company called Esker that aims to provide personalized treatments for people with autoimmune diseases. The company is based in San Francisco, CA. Esker uses a precision analytics platform, powered by foresite labs, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology to create medicines that change the lives of people with autoimmune disease. The company was founded by June H Lee. Martin Babler has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| 89BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Sardona Therapeutics, Inc. | Director/Board Member | ||
| OMEGA ALPHA SPAC | Financial Conglomerates | Director/Board Member | |
| KYMERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 47 |
| Canada | 2 |
| Nederland | 2 |
| Zwitserland | 2 |
| Ierland | 2 |
Sectoraal
| Health Technology | 32 |
| Consumer Services | 14 |
| Finance | 3 |
| Health Services | 3 |
| Commercial Services | 2 |
Operationeel
| Director/Board Member | 46 |
| Corporate Officer/Principal | 27 |
| Independent Dir/Board Member | 23 |
| Undergraduate Degree | 11 |
| Chief Tech/Sci/R&D Officer | 11 |
Sterkste connecties
| Insiders | |
|---|---|
| Julian Baker | 20 |
| Mardi Dier | 18 |
| Kelvin Neu | 13 |
| Martin Babler | 13 |
| Deborah Morosini | 10 |
| David Mauro | 9 |
| Victor Sandor | 9 |
| Laurent Chardonnet | 8 |
| Brian Piper | 8 |
| Andrew Combs | 7 |
| Christopher Slapak | 7 |
| Christopher Pierce | 6 |
| Stacey L. Jurchison | 5 |
| Michele Porreca | 5 |
- Beurs
- Insiders
- Adam Shilling
- Bedrijfsconnecties
